Skip to the content

Discovery outsourcing

Discovery outsourcing refers to the practice of outsourcing certain tasks or processes related to the drug discovery and development process.

  • Search

Search Results

“”

We found 500 results matching your search query.

  • 2023

  • FDA Approves Austedo XR Extended-Release Tablets for Huntington’s Disease

    13 Oct
  • Theravance, Viatris Seek to Block Copies of COPD Drug

    13 Oct
  • EU Authorizes CSL’s Gene Therapy for Hemophilia B

    13 Oct
  • Alzheimer’s Antibody Therapy from Eli Lilly Granted US FDA Breakthrough Therapy designation

    13 Oct
  • FDA creates task force to fast track COVID-19 drugs registration

    13 Oct
  • First-of-its-kind study examines the impact of cannabis use on surgical patients’ post-procedure healthcare needs

    13 Oct
  • FDA Approves Sanofi and Sobi’s Altuviiio for Hemophilia A

    13 Oct
  • Dr. Reddy’s bolsters US generics business with $105M deal to buy Mayne Pharma assets

    12 Oct
  • FDA Accepts IND and Grants Priority Review for SpringWorks Desmoid Tumors Therapeutic

    12 Oct
  • FDA Offers Advice on Macular Degeneration Drug Trials

    12 Oct

Older

© 2025 Discovery outsourcing

Theme by Anders Norén